FDA Updates Guidance on ‘Morning After’ Pill, Making Clear It Does Not Cause Abortions

Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas

For women with symptomatic uterine leiomyomas, ulipristal is well tolerated and superior to placebo for the rate of and time to amenorrhea, according to a study published online Feb. 5 in Obstetrics & Gynecology.

Many U.S. Teens Can’t Access Emergency Contraception

Although the U.S. Food and Drug Administration has lifted age restrictions on the use of levonorgestrel emergency contraception, many teens may still have difficulty obtaining the medication, according to a study published online June 30 in Pediatrics.